EXHIBIT 23.2

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

    We consent to the incorporation by reference in the Registration Statement
(Form S-3) and related prospectus of Titan Pharmaceuticals, Inc. for the
registration of 1,200,000 shares of its common stock of our report dated
February 24, 2000 (except for Note 14, as to which the date is March 3, 2000),
with respect to the consolidated financial statements of Titan
Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year
ended December 31, 1999 filed with the Securities and Exchange Commission.

Palo Alto, California
November 30, 2000